IPOS 2017 Keynote Speakers
The development of autobiographical meaning making in adolescence
Tilmann Habermas is a professor of Psychoanalysis at the Department of Psychology of the Goethe University Frankfurt. Formerly he studied the history and other aspects of eating disorders as well as the psychology of personal beloved objects. Currently he studies the role of narrating in expressing, communicating, and coping with emotions as well as the development of the ability to construct a coherent life story in adolescence. Special interests are the role of narrating for coping with critical life events
Managing Cancer and Living Meaningfully: CALM Before the Storm
Gary Rodin is the University of Toronto/University Health Network Harold and Shirley Lederman Chair in Psychosocial Oncology and Palliative Care and Head of the Department of Supportive Care at Princess Margaret Cancer Centre in Toronto, Canada. Dr. Rodin is also the Director of the Global Institute of Psychosocial, Palliative and End-of-Life Care (GIPPEC) and a Professor of Psychiatry at the University of Toronto. He leads a clinical and research program on the psychosocial dimensions of advanced and terminal disease and on the development and evaluation of novel interventions to improve the quality of life and the quality of dying and death in this population. These integrated psychosocial and palliative interventions include Managing Cancer and Living Meaningfully (CALM), a supportive-expressive psychotherapeutic treatment for patients with metastatic cancer and their caregivers, and an integrated emotion and symptom-focused intervention for individuals diagnosed with life-threatening hematological malignancies of acute onset. Through GIPPEC, a University of Toronto Interdisciplinary Institute based at Princess Margaret, Dr. Rodin has established international partnerships in Europe, Asia, Africa and the Middle East to contribute to global access to palliative and supportive care for patients and families facing advanced disease and the end of life. He has published widely in these areas and is recognized internationally for his efforts to improve the rigor of research and the effectiveness and availability of psychosocial and palliative interventions.
Marjan van den Akker
Comorbidity and well-being in older cancer survivors
Marjan van den Akker (PhD) is Associate Professor at the Department of Family Medicine of Maastricht University (Care and Public Health Research Institute; Caphri), The Netherlands. She is posted at the School Mental Health and NeuroScience (MHeNS) of Maastricht University, and is a guest lecturer at the Department of General Practice of the Catholic University of Leuven, Belgium. Marjan studied Health Sciences at Maastricht University, and later specialized in epidemiology. Her primary research interests lie in general practice, comorbidity, multimorbidity, polypharmacy, older patients with cancer, cohorts and longitudinal analyses
Future Research in Psycho-Oncology
Christoffer Johansen is a scientist, who has used his working life to investigate different issues related to cancer as a phenomenon. Major contributions are within the area of ‘mind & cancer’, ‘psychosocial interventions’, ‘depression in cancer patients’, ‘late effects in cancer patients’ and ‘descriptive psychosocial cancer epidemiology’. He has conducted clinical trials, and large-scale both clinical and epidemiological studies. Currently a professor at Oncology clinic, Rigshospitalet in Copenhagen and Head, Unit of Survivorship at the Danish Cancer Society Research Center. He is adjunct professor at Hamburg Eppendorf University Hospital, and Leipzig University, Germany. He has published widely and constantly during a career of more than 30 years. Professor Johansen served as President for IPOS in the years 2003 to 2006. IPOS has honoured him with the Kawano Young Investigator Award, The Fox Award and the Sutherland Award. He loves skiing, hiking on small islands, his green-house, winter bathing and his family now including grandchildren.
Irma Verdonck-de Leeuw
Meaning centered group psychotherapy in cancer survivors
Irma Verdonck-de Leeuw is professor “Psychosocial Oncology” at the Department of Clinical Psychology of the Vrije Universiteit Amsterdam and the Department of Otolaryngology – Head & Neck Surgery of VU University Medical Center, in Amsterdam, the Netherlands. She supervises 21 PhD students and is (co-)author of more than 140 peer reviewed publications. She is program leader of “Treatment and Quality of life” of the Research Institute Cancer Center Amsterdam (CCA). From 2013-2016, she was Secretary of the Executive Committee of the EORTC Quality of Life Group, and Chair of the MASCC Study Group on Cancer Survivorship, Rehabilitation, and Quality of Life. She was board member of the International Association of Logopedics and Phoniatrics (IALP) from 2004-2010.
Relevant patient-reported psychosocial outcome criteria in clinical studies
Matthias Rose is medical professor and director of the Department of Psychosomatic Medicine at the University Medical Center Berlin (Charité). He is specialist for internal medicine as well as psychosomatic medicine/psychotherapy. He has broad expertise in investigating the interplay between psychological and physiological aspects, with a focus on chronically ill patients and patient-centered care. An important part of his research consists in methodological validation, improvement and development of instruments including computer-adaptive testing for assessing quality of life, depression and other patient-reported outcome measures.
Lonneke van de Poll-Franse
Long term and late effects of cancer treatment
Lonneke van de Poll-Franse is Professor of Cancer Epidemiology and Survivorship at Tilburg University and group leader at the department of Psychosocial research and Epidemiology at the Netherlands Cancer Institute in Amsterdam, The Netherlands. Her research focuses on quality of life, quality of care and pharmaco-epidemiology in the field of cancer survivorship. Lonneke has a special research interest in the impact of cancer and its treatment on patient reported outcomes (symptoms, health related quality of life) during cancer survivorship. In 2009 she started the PROFILES (Patient Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship) registry that combines population-based cancer registry data with patient reported outcomes www.profilesregistry.nl<http://www.profilesregistry.nl>). She is an active member of the EORTC-QoL group and PI for the development of a lymphoma module and EORTC Cancer Survivorship questionnaire. She is currently chair of the EORTC-QoL group.
Reckoning with Risk: The implication of medical risk competence on cancer care delivery
Odette Wegwarth is a senior researcher at the Max Planck Institute for Human Development in Berlin. In 2007, she received her PhD for investigating decision-making of oncologists, pathologists and cancer patients on the use of pharmacodiagnostic tests at the Humboldt University Berlin. In 2015, she habilitated on medical risk competence of physicians and patients in the field of cancer screening/prevention at the Charité Berlin. Due to her research achievements, she was awarded with the "Early Investigator Award" of the American Society of Behavioral Medicine (2013) and the "Dr.-Lothar-Beyer-Preis" of the German Foundation for General Medicine (2016).
Improving Care Delivery for Cancer Survivors
Dr. Jacobsen is an Associate Director at the (U.S.) National Cancer Institute (NCI) where he leads the Healthcare Delivery Research Program. In this position, he heads a team whose mission is to support research to improve the delivery of cancer-related care, advance the science of patient-centered outcome assessment, and disseminate resources for use in population-level care delivery research. He also plays a key role in NCI’s collaborations with other agencies and organizations worldwide involved in cancer-related health services and outcomes research. Dr. Jacobsen has a particular interest in supportive care and is co-leading NCI’s current efforts to support research to improve symptom assessment and management as part of routine cancer care.
PSO Annual Conference Keynote Speakers
Please note that these Keynotes are part of the PSO Annual Conference and thus will be held in German.
Olaf v.d. Knesebeck
Social determinants of health - current status and relevance for oncology/Soziale Determinanten von Gesundheit - Forschungsstand und Bezug zur Onkologie
Olaf v.d. Knesebeck is the Director of the Department of Medical Sociology at the University Medical Centre Hamburg-Eppendorf (Germany). His research interests include social determinants of health and health care, international comparisons in health services research, health surveys, mental health literacy and stigma.
Socio-economic disparities in psycho-oncology/Sozioökonomische Ungleichheit in der Psychoonkologie
Susanne Singer graduated from the School of Psychology of Leipzig University, Germany, in 1999. She worked as a Clinical Psychologist and Research Fellow at the departments of Mental Health Epidemiology and Social Medicine at Leipzig University between 1999 and 2012, earning her PhD degree in 2005. From 2008 to 2009, she attended the London School of Hygiene and Tropical Medicine in London, UK, for a Master of Science in Epidemiology. From 2009 to 2012, she was Senior Researcher and Senior Lecturer at Leipzig University, at the Department of Medical Psychology and Medical Sociology, earning her habilitation in 2010. In 2012, she became Full Professor of Epidemiology and chair of the Division of Epidemiology and Health Services Research at the Institute of Medical Biostatistics, Epidemiology and Informatics of University Medical Centre of Johannes Gutenberg-University Mainz. Her main research interests are Quality of Life and Quality of Care in cancer patients. Susanne Singer is an active member of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life and EORTC Head and Neck Cancer groups where she also serves at the Executive Committee.